Site augmentation emerges as a dynamic response to the growing complexity and volume of clinical trials, and the challenge of limited resources at clinical research sites. This support model, which is ...

The benefits and risks of augmenting or switching antidepressants in older adults with treatment-resistant depression have not been extensively studied. We conducted a two-step, open-label trial ...